AMENDED AND RESTATED REVOLVING CREDIT AGREEMENTRevolving Credit Agreement • August 30th, 2019 • AbbVie Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 30th, 2019 Company Industry JurisdictionThis Amended and Restated Revolving Credit Agreement (this “Agreement”) dated as of August 27, 2019 is among AbbVie Inc., a corporation organized and existing under the laws of the State of Delaware (the “Borrower”), the Lenders (as defined below) that are parties hereto, and JPMorgan Chase Bank, N.A., as administrative agent (together with any successor thereto appointed pursuant to Article VII, and including any applicable designated Affiliate, the “Administrative Agent”) for the Lenders.
This FIRST AMENDMENT, dated as of July 12, 2019 (this “Amendment Agreement”), to that certain Revolving Credit Agreement, dated as of August 31, 2018 (as amended from time to time prior to the date hereof, the “Existing Credit Agreement”), by and...Revolving Credit Agreement • July 16th, 2019 • AbbVie Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 16th, 2019 Company Industry JurisdictionThis Revolving Credit Agreement (this “Agreement”) dated as of August 31, 2018 is among AbbVie Inc., a corporation organized and existing under the laws of the State of Delaware (the “Borrower”), the Lenders (as defined below) that are parties hereto, and JPMorgan Chase Bank, N.A., as administrative agent (together with any successor thereto appointed pursuant to Article VII, and including any applicable designated Affiliate, the “Administrative Agent”) for the Lenders.
REVOLVING CREDIT AGREEMENT Dated as of August 31, 2018 among ABBVIE INC., as Borrower, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and JPMORGAN CHASE BANK, N.A. as Administrative Agent BANK OF AMERICA, N.A. and MORGAN STANLEY SENIOR FUNDING, INC. as...Revolving Credit Agreement • September 6th, 2018 • AbbVie Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 6th, 2018 Company Industry JurisdictionThis Revolving Credit Agreement (this “Agreement”) dated as of August 31, 2018 is among AbbVie Inc., a corporation organized and existing under the laws of the State of Delaware (the “Borrower”), the Lenders (as defined below) that are parties hereto, and JPMorgan Chase Bank, N.A., as administrative agent (together with any successor thereto appointed pursuant to Article VII, and including any applicable designated Affiliate, the “Administrative Agent”) for the Lenders.
REVOLVING CREDIT AGREEMENT Dated as of August 18, 2014 among ABBVIE INC. and ABBVIE PRIVATE LIMITED, as Borrowers, the GUARANTOR party hereto, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and JPMORGAN CHASE BANK, N.A. as Administrative AgentRevolving Credit Agreement • August 21st, 2014 • AbbVie Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 21st, 2014 Company Industry JurisdictionThis Revolving Credit Agreement (this “Agreement”) dated as of August 18, 2014 is among AbbVie Inc., a corporation organized and existing under the laws of Delaware (“AbbVie”), AbbVie Private Limited, a private limited company organized and existing under the laws of Jersey (“AbbVie NewCo” and, together with AbbVie, each a “Borrower” and collectively the “Borrowers”), the Guarantor (as defined below) that is party hereto, the Lenders (as defined below) that are parties hereto, and JPMorgan Chase Bank, N.A., as administrative agent (together with any successor thereto appointed pursuant to Article VII, and including any applicable designated Affiliate, the “Administrative Agent”) for the Lenders.